Micromolecular methods for diagnosis and therapeutic strategy: a case study

An intraductal carcinoma, 55 mm across, was diagnosed on a total mastectomy in a 45-year-old woman. The 2 micro-invasive areas found were too small for reliable immunostainings for estrogen, progesterone, and HER2 receptors. In the sentinel lymph-node, a subcapsular tumor embole of about 50 cancer c...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget 2018-04, Vol.9 (32), p.22862-22869
Main Authors: Elbouchtaoui, Morad, Tengher, Iulia, Miquel, Catherine, Brugière, Charlotte, Benbara, Amélie, Zelek, Laurent, Ziol, Marianne, Bouhidel, Fatiha, Janin, Anne, Bousquet, Guilhem, Leboeuf, Christophe
Format: Article
Language:English
Subjects:
Cancer
Case Report
Life Sciences
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An intraductal carcinoma, 55 mm across, was diagnosed on a total mastectomy in a 45-year-old woman. The 2 micro-invasive areas found were too small for reliable immunostainings for estrogen, progesterone, and HER2 receptors. In the sentinel lymph-node, a subcapsular tumor embole of about 50 cancer cells was identified on the extemporaneous cryo-cut section, but not on further sections after paraffin-embedding of the sample. Considering this tumor metastatic potential, we decided to assess HER2 status on the metastatic embole using pathological and molecular micro-methods. We laser-microdissected the tumor cells, extracted their DNA, and performed droplet-digital-PCR (ddPCR) for HER2 gene copy number variation. The allele ratio was 5.2 in the laser-microdissected tumor cells, similar to the 5.3 ratio in the HER2-overexpressing breast cancer cell line BT-474. We thus optimized the adjuvant treatment of our patient and she received a trastuzumab-based adjuvant chemotherapy.
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.25161